Connect with us

Share

Follow Masterillness on Twitter
Browse Categories
Newsletter Archive

Testimonials

Browse Categories
Browse Categories
Mailing Lists
SIGN UP FOR OUR NEWSLETTER

Newsletter Archive
back to Newsletter Archive
Anti-retroviral therapy might increase the risk of cancers in HIV patients.

HIV positive patients are 60% percent more likely to have lung, Hodgkin's, melanoma or liver cancer than patients without HIV, after adjusting for age, race, and gender. The researchers examined all forms of cancer, except AIDS-defining malignancies (skin, lymphoma, cervical carcinoma, Kaposi's sarcoma and ill-defined cancers). The increased number of non-AIDS-defining malignancies is not simply the result of their longer lives, according to Dr Roger Bedimo.

One controversial theory is that the anti-retroviral therapy itself might increase the risk of those cancers in HIV patients. "The second hypothesis is that HIV-infected patients somehow, either by their lifestyle or other circumstances, are more subject to the traditional risk factors than non-HIV patients," Dr. Bedimo said. "The third hypothesis is that HIV or another undetected virus increases a patient's risk for developing cancer intrinsically."

Consider I3C and Vitamin D for reducing cancer risk.

Press Release

Scientific journal article